KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
  South Korea
 South Korea  · Delayed Price · Currency is KRW  
621.00
 -18.00 (-2.82%)
  At close: Oct 29, 2025
 
 KMPHARMACEUTICAL Ratios and Metrics
 Market cap in millions KRW. Fiscal year is January - December.
 Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 
|---|
| Oct '25 Oct 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 
|---|
|  | 17,290 | 19,103 | 27,274 | 44,340 | 62,049 | 81,291 |  | 
|  | -19.06% | -29.96% | -38.49% | -28.54% | -23.67% | 36.48% |  | 
|  | 31,977 | 32,128 | 39,519 | 56,196 | 64,798 | 98,622 |  | 
|  | 620.00 | 685.00 | 978.00 | 1590.00 | 2225.00 | 2915.00 |  | 
|  | - | - | - | - | - | 172.64 |  | 
|  | 1.23 | 1.32 | 1.54 | 2.84 | 2.73 | 3.55 |  | 
|  | 0.56 | 0.59 | 0.77 | 1.22 | 1.56 | 1.99 |  | 
|  | 0.56 | 0.59 | 0.77 | 1.22 | 1.56 | 2.00 |  | 
|  | - | - | 20.45 | - | - | - |  | 
|  | - | - | 18.86 | - | 27.37 | 89.41 |  | 
|  | 2.28 | 2.22 | 2.22 | 3.60 | 2.85 | 4.30 |  | 
|  | - | - | 154.53 | - | 28.07 | 53.18 |  | 
|  | - | - | - | - | 74.81 | 138.45 |  | 
|  | -12.37 | - | 29.64 | - | - | - |  | 
|  | 0.48 | 0.43 | 0.35 | 0.37 | 0.24 | 0.18 |  | 
|  | - | - | 48.67 | - | 4.19 | 4.04 |  | 
|  | - | - | 9.34 | - | - | - |  | 
|  | 0.29 | 0.29 | 0.35 | 0.30 | 0.44 | 0.49 |  | 
|  | 4.48 | 4.52 | 5.32 | 4.76 | 5.80 | 5.37 |  | 
|  | 0.12 | 0.23 | 0.28 | 0.23 | 0.86 | 2.80 |  | 
|  | 0.41 | 0.51 | 0.50 | 0.51 | 1.32 | 3.90 |  | 
|  | -14.29% | -13.43% | -3.68% | -10.30% | -1.52% | 1.45% |  | 
|  | -4.78% | -4.83% | -1.37% | -4.47% | 1.05% | 0.95% |  | 
|  | -5.00% | -5.08% | -1.43% | -4.69% | 1.11% | 1.00% |  | 
| Return on Capital Employed (ROCE) | - | - | - | - | 1.90% | 1.50% |  | 
|  | -26.68% | -23.94% | -4.84% | -8.85% | -0.98% | 0.58% |  | 
|  | -14.95% | -12.57% | 4.89% | -0.34% | -0.16% | -3.48% |  | 
|  | 0.30% | 0.71% | -0.90% | -0.20% | -29.80% | -2.06% |  | 
Source: S&P Global Market Intelligence. Standard template. 
Financial Sources.